Shionogi, Response Biomedical to Conclude Sales Agreement for Rapid BNP Test.
SHIONOSPOT BNP, which is based on fluorescent immunochromatographic assay, can measure the levels of B-type natriuretic peptide (BNP) in the blood. BNP is a kind of hormone that reflects deterioration in heart functions.
Used in combination with the SHIONOSPOT Reader, the reagent can obtain results in about 16 minutes. Shionogi expects that the launch of SHIONOSPOT will contribute to the diagnosis and management of congestive heart failure at clinical sites.
Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||May 19, 2006|
|Previous Article:||Fujitsu Develops Plant Plastic with Higher Impact-Resistance.|
|Next Article:||Yakult Honsha to Bring to Market New Intestinal Remedy in June.|